Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZYMERGEN INC.

(ZY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Zymergen : HSBC Downgrades Zymergen to Reduce From Hold; Price Target is $8

08/04/2021 | 05:47am EDT


ę MT Newswires 2021
All news about ZYMERGEN INC.
09/23ZYMERGEN : Cuts 120 Jobs as Part of Restructuring Program to Align Group Costs With Delaye..
MT
09/23ZYMERGEN INC. : Other Events (form 8-K)
AQ
09/23ZYMERGEN : The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Act..
PR
09/20ZYMERGEN : ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Zymergen Inc. Investors with L..
PR
09/20DEADLINE REMINDER : Law Offices of Howard G. Smith Reminds Investors of Looming Deadline i..
PR
09/20ZYMERGEN INC.(NASDAQGS : ZY) added to S&P Global BMI Index
CI
09/17KESSLER TOPAZ MELTZER & CHECK, LLP : Reminds Investors Of Deadline For Securities Fraud Cl..
PR
09/17GLANCY PRONGAY & MURRAY LLP : Reminds Investors of Looming Deadline in the Class Action La..
PR
09/10ZYMERGEN INC. (NASDAQ : ZY) LAWSUIT FILING DEADLINE: Bernstein Liebhard LLP Reminds Invest..
PR
09/07ZYMERGEN INC. CLASS ACTION ALERT : Wolf Haldenstein Adler Freeman & Herz LLP reminds inves..
PR
More news
Analyst Recommendations on ZYMERGEN INC.
More recommendations
Financials (USD)
Sales 2021 17,7 M - -
Net income 2021 -361 M - -
Net cash 2021 347 M - -
P/E ratio 2021 -3,49x
Yield 2021 -
Capitalization 1 413 M 1 413 M -
EV / Sales 2021 60,3x
EV / Sales 2022 40,4x
Nbr of Employees 758
Free-Float 91,1%
Chart ZYMERGEN INC.
Duration : Period :
Zymergen Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZYMERGEN INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 7
Last Close Price 13,80 $
Average target price 10,40 $
Spread / Average Target -24,6%
EPS Revisions
Managers and Directors
Jay T. Flatley Chairman & Chief Executive Officer
Enakshi Singh Chief Financial Officer
Zachariah Serber Director & Chief Science Officer
Jed Dean Vice President-Operations & Engineering
Aaron Kimball Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
ZYMERGEN INC.0.00%1 413
PROCTER & GAMBLE COMPANY3.63%350 139
UNILEVER PLC-9.13%141 439
THE ESTÉE LAUDER COMPANIES INC.20.71%116 089
HINDUSTAN UNILEVER LIMITED16.22%88 613
COLGATE-PALMOLIVE COMPANY-10.34%64 672